84 related articles for article (PubMed ID: 22764537)
21. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
Li L; Tian YJ; Shen H; Zhao XP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
[TBL] [Abstract][Full Text] [Related]
22. [Humoral and cellular immunogenecity of genetic vaccine on core gene of hepatitis B virus in mice].
Huang Z; Lu S; Liu N
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):456-9. PubMed ID: 11715443
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.
Liu CJ; Jeng YM; Chen CL; Cheng HR; Chen PJ; Chen TC; Liu CH; Lai MY; Chen DS; Kao JH
J Infect Dis; 2009 Mar; 199(5):742-9. PubMed ID: 19199543
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cell-based vaccination with lentiviral vectors encoding ubiquitinated hepatitis B core antigen enhances hepatitis B virus-specific immune responses in vivo.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Tang Z; Zang G
Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):870-9. PubMed ID: 26373843
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of the immunogenicity of hepatitis B core antigen in a hepatitis B e antigen polypeptide (P19).
Takahashi K; Imai M; Nomura M; Oinuma A; Machida A; Funatsu G; Miyakawa Y; Mayumi M
J Gen Virol; 1981 Dec; 57(Pt 2):325-30. PubMed ID: 6172555
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
[TBL] [Abstract][Full Text] [Related]
27. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.
Clarke BE; Newton SE; Carroll AR; Francis MJ; Appleyard G; Syred AD; Highfield PE; Rowlands DJ; Brown F
Nature; 1987 Nov 26-Dec 2; 330(6146):381-4. PubMed ID: 2446137
[TBL] [Abstract][Full Text] [Related]
28. In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA.
Rosmorduc O; Petit MA; Pol S; Capel F; Bortolotti F; Berthelot P; Brechot C; Kremsdorf D
Hepatology; 1995 Jul; 22(1):10-9. PubMed ID: 7601398
[TBL] [Abstract][Full Text] [Related]
29. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.
Milich DR; McLachlan A; Moriarty A; Thornton GB
J Immunol; 1987 Aug; 139(4):1223-31. PubMed ID: 2440947
[TBL] [Abstract][Full Text] [Related]
30. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
31. [Synthesis of hepatitis B virus core antigen (HBcAg) particles by recombinant vaccinia virus].
Loparev VN; Araslanov RR; Mitina IV; Antonova TP; Ianova NN; Iashina TL; Chernos VI
Mol Gen Mikrobiol Virusol; 1990 Oct; (10):18-22. PubMed ID: 1702184
[No Abstract] [Full Text] [Related]
32. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
33. A bi-functional hepatitis B virus core antigen (HBcAg) chimera activates HBcAg-specific T cells and preS1-specific antibodies.
Malik IR; Chen A; Brass A; Ahlén G; Rahman M; Sällberg M; Qureshi JA; Frelin L
Scand J Infect Dis; 2012 Jan; 44(1):55-9. PubMed ID: 21933033
[TBL] [Abstract][Full Text] [Related]
34. The use of viral vectors to produce hepatitis B virus core particles in plants.
Mechtcheriakova IA; Eldarov MA; Nicholson L; Shanks M; Skryabin KG; Lomonossoff GP
J Virol Methods; 2006 Jan; 131(1):10-5. PubMed ID: 16112207
[TBL] [Abstract][Full Text] [Related]
35. Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms.
Billaud JN; Peterson D; Lee BO; Maruyama T; Chen A; Sallberg M; Garduño F; Goldstein P; Hughes J; Jones J; Milich D
Vaccine; 2007 Feb; 25(9):1593-606. PubMed ID: 17178179
[TBL] [Abstract][Full Text] [Related]
36. Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.
Takashima H; Araki K; Miyazaki J; Yamamura K; Kimoto M
Immunology; 1992 Mar; 75(3):398-405. PubMed ID: 1533387
[TBL] [Abstract][Full Text] [Related]
37. SplitCore Technology Allows Efficient Production of Virus-Like Particles Presenting a Receptor-Contacting Epitope of Human IgE.
Baltabekova AZh; Shagyrova ZhS; Kamzina AS; Voykov M; Zhiyenbay Y; Ramanculov EM; Shustov AV
Mol Biotechnol; 2015 Aug; 57(8):746-55. PubMed ID: 25837568
[TBL] [Abstract][Full Text] [Related]
38. Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.
Yin Y; Zhang S; Cai C; Zhang J; Dong D; Guo Q; Fu L; Xu J; Chen W
Immunobiology; 2014 Feb; 219(2):97-103. PubMed ID: 24054942
[TBL] [Abstract][Full Text] [Related]
39. [Immunogenicity of new DNA vaccine encoding for hepatitis B virus core antigen].
Xing YP; Huang ZH; Wang SX; Cai J; Li J; Lu S
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):338-40. PubMed ID: 15225426
[TBL] [Abstract][Full Text] [Related]
40. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
